Summary

Multiplex PCR Market – Scope of Report
TMR’s report on the global multiplex PCR market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global multiplex PCR market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global multiplex PCR market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the multiplex PCR market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global multiplex PCR market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global multiplex PCR market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global multiplex PCR market.

The report delves into the competitive landscape of the global multiplex PCR market. Key players operating in the global multiplex PCR market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global multiplex PCR market profiled in this report.

Key Questions Answered in Global multiplex PCR Market Report
• What is the sales/revenue generated by multiplex PCR across all regions during the forecast period?
• What are the opportunities in the global multiplex PCR market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Multiplex PCR Market – Research Objectives and Research Approach
The comprehensive report on the global multiplex PCR market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global multiplex PCR market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global multiplex PCR market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Multiplex PCR Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Multiplex PCR Market Analysis and Forecast, 2020-2034
5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Product/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Multiplex PCR Market Analysis and Forecast, by Products & Services
    6.1. Introduction and Definitions
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Products & Services, 2020-2034
        6.3.1. Consumables
        6.3.2. Instruments
        6.3.3. Software’s and Services
    6.4. Market Attractiveness, by Products & Services
7. Global Multiplex PCR Market Analysis and Forecast, by Assay Type
    7.1. Introduction and Definitions
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Assay Type, 2020-2034
        7.3.1. Planar Assay
            7.3.1.1. Blends Protein Assays (Multiplexed ELISA)
            7.3.1.2. Antibody Assays
        7.3.2. Bead-based Assay
            7.3.2.1. Magnetic Bead-based
            7.3.2.2. Non-Magnetic Bead-based
        7.3.3. 7.4 Market Attractiveness, by Assay Type
8. Global Multiplex PCR Market Analysis and Forecast, by Application
    8.1. Introduction and Definitions
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Application, 2020-2034
        8.3.1. Disease Diagnosis
        8.3.2. Research & Development
        8.3.3. Others (Clinical Diagnostics, etc.)
    8.4. Market Attractiveness, by Application
9. Global Multiplex PCR Market Analysis and Forecast, by End-user
    9.1. Introduction and Definitions
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by End-user, 2020-2034
        9.3.1. Biopharmaceutical Companies
        9.3.2. Clinical Research Organizations
        9.3.3. Academic Research Institutes
        9.3.4. Others (Diagnostic Centers, etc.)
    9.4. Market Attractiveness, by End-user
10. Global Multiplex PCR Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region, 2020-2034
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness, by Region
11. North America Multiplex PCR Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Products & Services, 2020-2034
        11.2.1. Consumables
        11.2.2. Instruments
        11.2.3. Software’s and Services
    11.3. Market Attractiveness, by Products & Services
    11.4. Market Value Forecast, by Assay Type, 2020-2034
        11.4.1. Planar Assay
            11.4.1.1. Blends Protein Assays (Multiplexed ELISA)
            11.4.1.2. Antibody Assays
        11.4.2. Bead-based Assay
            11.4.2.1. Magnetic Bead-based
            11.4.2.2. Non-Magnetic Bead-based
    11.5. Market Attractiveness, by Assay Type
    11.6. Market Value Forecast, by Application, 2020-2034
        11.6.1. Disease Diagnosis
        11.6.2. Research & Development
        11.6.3. Others (Clinical Diagnostics, etc.)
    11.7. Market Attractiveness, by Application
    11.8. Market Value Forecast, by End-user, 2020-2034
        11.8.1. Biopharmaceutical Companies
        11.8.2. Clinical Research Organizations
        11.8.3. Academic Research Institutes
        11.8.4. Others (Diagnostic Centers, etc.)
    11.9. Market Attractiveness, by End-user
    11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
        11.10.1. U.S.
        11.10.2. Canada
    11.11. Market Attractiveness Analysis
        11.11.1. By Products & Services
        11.11.2. By Assay Type
        11.11.3. By Application
        11.11.4. By End-user
        11.11.5. By Country
12. Europe Multiplex PCR Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Products & Services, 2020-2034
        12.2.1. Consumables
        12.2.2. Instruments
        12.2.3. Software’s and Services
    12.3. Market Attractiveness, by Products & Services
    12.4. Market Value Forecast, by Assay Type, 2020-2034
        12.4.1. Planar Assay
            12.4.1.1. Blends Protein Assays (Multiplexed ELISA)
            12.4.1.2. Antibody Assays
        12.4.2. Bead-based Assay
            12.4.2.1. Magnetic Bead-based
            12.4.2.2. Non-Magnetic Bead-based
    12.5. Market Attractiveness, by Assay Type
    12.6. Market Value Forecast, by Application, 2020-2034
        12.6.1. Disease Diagnosis
        12.6.2. Research & Development
        12.6.3. Others (Clinical Diagnostics, etc.)
    12.7. Market Attractiveness, by Application
    12.8. Market Value Forecast, by End-user, 2020-2034
        12.8.1. Biopharmaceutical Companies
        12.8.2. Clinical Research Organizations
        12.8.3. Academic Research Institutes
        12.8.4. Others (Diagnostic Centers, etc.)
    12.9. Market Attractiveness, by End-user
    12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
        12.10.1. Germany
        12.10.2. U.K.
        12.10.3. France
        12.10.4. Italy
        12.10.5. Spain
        12.10.6. Rest of Europe
    12.11. Market Attractiveness Analysis
        12.11.1. By Products & Services
        12.11.2. By Assay Type
        12.11.3. By Application
        12.11.4. By End-user
        12.11.5. By Country/Sub-region
13. Asia Pacific Multiplex PCR Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Products & Services, 2020-2034
        13.2.1. Consumables
        13.2.2. Instruments
        13.2.3. Software’s and Services
    13.3. Market Attractiveness, by Products & Services
    13.4. Market Value Forecast, by Assay Type, 2020-2034
        13.4.1. Planar Assay
            13.4.1.1. Blends Protein Assays (Multiplexed ELISA)
            13.4.1.2. Antibody Assays
        13.4.2. Bead-based Assay
            13.4.2.1. Magnetic Bead-based
            13.4.2.2. Non-Magnetic Bead-based
    13.5. Market Attractiveness, by Assay Type
    13.6. Market Value Forecast, by Application, 2020-2034
        13.6.1. Disease Diagnosis
        13.6.2. Research & Development
        13.6.3. Others (Clinical Diagnostics, etc.)
    13.7. Market Attractiveness, by Application
    13.8. Market Value Forecast, by End-user, 2020-2034
        13.8.1. Biopharmaceutical Companies
        13.8.2. Clinical Research Organizations
        13.8.3. Academic Research Institutes
        13.8.4. Others (Diagnostic Centers, etc.)
    13.9. Market Attractiveness, by End-user
    13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
        13.10.1. China
        13.10.2. Japan
        13.10.3. India
        13.10.4. Australia & New Zealand
        13.10.5. Rest of Asia Pacific
    13.11. Market Attractiveness Analysis
        13.11.1. By Products & Services
        13.11.2. By Assay Type
        13.11.3. By Application
        13.11.4. By End-user
        13.11.5. By Country/Sub-region
14. Latin America Multiplex PCR Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Products & Services, 2020-2034
        14.2.1. Consumables
        14.2.2. Instruments
        14.2.3. Software’s and Services
    14.3. Market Attractiveness, by Products & Services
    14.4. Market Value Forecast, by Assay Type, 2020-2034
        14.4.1. Planar Assay
            14.4.1.1. Blends Protein Assays (Multiplexed ELISA)
            14.4.1.2. Antibody Assays
        14.4.2. Bead-based Assay
            14.4.2.1. Magnetic Bead-based
            14.4.2.2. Non-Magnetic Bead-based
    14.5. Market Attractiveness, by Assay Type
    14.6. Market Value Forecast, by Application, 2020-2034
        14.6.1. Disease Diagnosis
        14.6.2. Research & Development
        14.6.3. Others (Clinical Diagnostics, etc.)
    14.7. Market Attractiveness, by Application
    14.8. Market Value Forecast, by End-user, 2020-2034
        14.8.1. Biopharmaceutical Companies
        14.8.2. Clinical Research Organizations
        14.8.3. Academic Research Institutes
        14.8.4. Others (Diagnostic Centers, etc.)
    14.9. Market Attractiveness, by End-user
    14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
        14.10.1. Brazil
        14.10.2. Mexico
        14.10.3. Rest of Latin America
    14.11. Market Attractiveness Analysis
        14.11.1. By Products & Services
        14.11.2. By Assay Type
        14.11.3. By Application
        14.11.4. By End-user
        14.11.5. By Country/Sub-region
15. Middle East & Africa Multiplex PCR Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Products & Services, 2020-2034
        15.2.1. Consumables
        15.2.2. Instruments
        15.2.3. Software’s and Services
    15.3. Market Attractiveness, by Products & Services
    15.4. Market Value Forecast, by Assay Type, 2020-2034
        15.4.1. Planar Assay
            15.4.1.1. Blends Protein Assays (Multiplexed ELISA)
            15.4.1.2. Antibody Assays
        15.4.2. Bead-based Assay
            15.4.2.1. Magnetic Bead-based
            15.4.2.2. Non-Magnetic Bead-based
    15.5. Market Attractiveness, by Assay Type
    15.6. Market Value Forecast, by Application, 2020-2034
        15.6.1. Disease Diagnosis
        15.6.2. Research & Development
        15.6.3. Others (Clinical Diagnostics, etc.)
    15.7. Market Attractiveness, by Application
    15.8. Market Value Forecast, by End-user, 2020-2034
        15.8.1. Biopharmaceutical Companies
        15.8.2. Clinical Research Organizations
        15.8.3. Academic Research Institutes
        15.8.4. Others (Diagnostic Centers, etc.)
    15.9. Market Attractiveness, by End-user
    15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
        15.10.1. GCC Countries
        15.10.2. South Africa
        15.10.3. Rest of Middle East & Africa
    15.11. Market Attractiveness Analysis
        15.11.1. By Products & Services
        15.11.2. By Assay Type
        15.11.3. By Application
        15.11.4. By End-user
        15.11.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
    16.2. Market Share Analysis, by Company (2023)
    16.3. Company Profiles
        16.3.1. Thermo Fisher Scientific
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Bio-Rad Laboratories, Inc.
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. QIAGEN N.V.
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Luminex Corporation
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Standard BioTools Inc.
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. BioFire Diagnostics
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. Becton, Dickinson and Company
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. DiaSorin
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Seegene Inc
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. Illumina, Inc.
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview